Clinical Trial Update: Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

View source ↗

Summary

ClinicalTrials.gov entry for a HealthPartners Institute study recruiting to assess claims about cannabis as a potential anti-cancer agent (CATA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: HealthPartners Institute | Conditions: Cancer, Cancer (With or Without Metastasis) | Status: RECRUITING